Drug intelligence / Profile preview

Xiaozheng Sanjie

Development stage: Preclinical
Lead developer: Sichuan Provincial Department of Science and Technology
Administration: Topical

Overview

Xiaozheng Sanjie is a Traditional Chinese Medicine (TCM) recipe currently under investigation for the treatment of chronic kidney disease. It is described as a compound formula and is being studied in clinical trials to evaluate its efficacy based on traditional Chinese medicine flaccidity theory.

Other names: 消癥散结中药复方

Beyond the preview

Go deeper on Xiaozheng Sanjie.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaozheng Sanjie.